Staphylococcus Aureus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Probiotic Markedly Reduces Staphylococcus Aureus Colonization in Phase 2 Trial
NIH study provides new insights on role of gut in staph colonization. January 17, 2023 -- A promising approach to control Staphylococcus aureus bacterial colonization in people– using a probiotic instead of antibiotics– was safe... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 17, 2023 Category: Pharmaceuticals Source Type: clinical trials

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
Condition: Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Interventions: Drug: FLU or CZO as continuous infusion; Drug: standard FLU or CZO intermittent bolus administration Sponsor: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia
Condition: Drug Resistance, Microbial Intervention: Sponsors: Erasmus Medical Center; Dr. Soetomo General Hospital; Balai Besar Laboratorium Kesehatan (BBLK) Surabaya; National Institute of Health Research and Development, Ministry of Health Republic of Indonesia; Directorate of Veterinary Public Health, Ministry of Agriculture, Indonesia; Directorate of Animal Health, Ministry of Agriculture, Indonesia; Ministry of Marine and Fisheries, Indonesia; Utrecht University; Radboud University Medical Center; National Institute for Public Health and the Environment (RIVM) Not ye...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials